NBIX - Neurocrine Biosciences Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - NBIX (914475)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
83 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-11-01
NBIXLyons Gary ADirS - Sale$100.22-5,000230,697-2%-$501,104
D
2019-11-01
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$100.34-10,188108,408-9%-$1,022,298
D
2019-10-14
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$90.85-9,95619,613-34%-$904,487
2019-10-02
NBIXCooke JulieCHROS - Sale$88.56-9873,276-23%-$87,409
D
2019-09-03
NBIXLippoldt DarinGCS - Sale+OE$100.00-6,73620,103-25%-$673,600
DM
2019-08-23
NBIXLippoldt DarinGCS - Sale+OE$100.05-3,26419,961-14%-$326,555
DM
2019-08-06
NBIXGorman Kevin CharlesCEOS - Sale+OE$95.31-80,000417,597-16%-$7,624,975
2019-07-30
NBIXLyons Gary ADirS - Sale$92.07-10,000235,697-4%-$920,686
D
2019-07-30
NBIXLippoldt DarinGCS - Sale+OE$92.13-15,83119,961-44%-$1,458,569
D
2019-07-30
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$92.92-60,000108,408-36%-$5,575,438
D
2019-07-30
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$92.77-44,356141,976-24%-$4,114,858
D
2019-07-15
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.50-30,680141,976-18%-$2,684,506
2019-07-15
NBIXBenevich EricChief Commercial OfficerS - Sale$87.44-5,83514,910-28%-$510,201
DM
2019-07-10
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.63-7,220141,976-5%-$632,717
D
2019-06-18
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.82-2,100141,976-1%-$184,417
D
2019-06-13
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$82.62-17,268141,976-11%-$1,426,628
D
2019-06-03
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$85.51-3,435141,976-2%-$293,719
D
2019-05-31
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$85.02-19,297141,976-12%-$1,640,581
D
2019-05-24
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.03-17,486141,976-11%-$1,399,434
D
2019-05-22
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.03-1,300141,976-1%-$104,037
D
2019-05-16
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.13-66,667141,976-32%-$5,341,893
2019-05-13
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$75.44-1,657118,408-1%-$125,007
D
2019-05-13
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$75.51-34,547141,976-20%-$2,608,813
D
2019-02-06
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$83.58-92019,238-5%-$76,894
D
2019-02-06
NBIXLippoldt DarinGCS - Sale+OE$83.52-79119,646-4%-$66,063
D
2019-02-06
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$84.03-531120,0650%-$44,622
D
2019-02-06
NBIXGorman Kevin CharlesCEOS - Sale+OE$84.22-4,096417,597-1%-$344,986
D
2019-02-06
NBIXGano KyleChief Business Development OffS - Sale+OE$83.56-76285,833-1%-$63,673
D
2019-02-06
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$83.54-920141,639-1%-$76,859
D
2019-02-06
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$83.57-92020,745-4%-$76,883
2019-02-05
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale$88.14-1,27217,508-7%-$112,119
2019-02-05
NBIXLippoldt DarinGCS - Sale$88.09-1,22518,162-6%-$107,911
M
2019-02-04
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$88.14-2,445119,071-2%-$215,505
M
2019-02-04
NBIXGorman Kevin CharlesCEOS - Sale$88.16-7,614413,943-2%-$671,216
M
2019-02-04
NBIXGano KyleChief Business Development OffS - Sale$88.12-3,80984,695-4%-$335,668
M
2019-02-04
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale$88.12-2,725139,909-2%-$240,125
2019-02-05
NBIXBenevich EricChief Commercial OfficerS - Sale$88.01-1,35719,015-7%-$119,427
2019-01-08
NBIXRoberts EiryChief Medical OfficerS - Sale$84.09-1,8573,143-37%-$156,159
2018-12-03
NBIXAbernethy MattCFOS - Sale$90.00-1,1781,947-38%-$106,020
2018-11-26
NBIXPops Richard FDirS - Sale$91.37-4,12429,512-12%-$376,790
2018-11-12
NBIXPops Richard FDirS - Sale$103.30-4,12333,636-11%-$425,893
D
2018-11-08
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$110.00-36,295135,997-21%-$3,992,450
DM
2018-11-06
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$110.13-38,819135,997-22%-$4,275,300
DM
2018-11-06
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$110.01-9,00015,318-37%-$990,096
2018-11-02
NBIXLyons Gary ADirS - Sale$114.41-15,000245,697-6%-$1,716,213
2018-10-29
NBIXPops Richard FDirS - Sale$107.13-5,50037,759-13%-$589,237
D
2018-08-01
NBIXGano KyleChief Business Development OffS - Sale+OE$115.00-28,26678,742-26%-$3,250,590
D
2018-08-01
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$110.00-23,02282,942-22%-$2,532,420
D
2018-06-20
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$105.00-23,00082,942-22%-$2,415,000
2018-06-13
NBIXLyons Gary ADirS - Sale$99.24-15,000260,697-5%-$1,488,549
DM
2018-06-13
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$99.48-86,96382,942-51%-$8,650,738
2018-06-11
NBIXSherwin Stephen ADirS - Sale$98.44-10,00047,548-17%-$984,420
2018-06-01
NBIXBenevich EricChief Commercial OfficerS - Sale$97.34-12,35016,690-43%-$1,202,164
2018-05-07
NBIXNevinny Corinne HDirS - Sale$83.12-5,00043,283-10%-$415,625
D
2018-05-01
NBIXGorman Kevin CharlesCEOS - Sale+OE$80.75-126,832347,033-27%-$10,241,735
D
2018-03-05
NBIXLippoldt DarinGCS - Sale+OE$88.47-1,97916,062-11%-$175,090
D
2018-03-05
NBIXGano KyleChief Business Development OffS - Sale+OE$90.00-23,65078,742-23%-$2,128,500
D
2018-03-05
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$90.00-75,873135,997-36%-$6,828,570
2018-02-15
NBIXLyons Gary ADirS - Sale$84.67-5,000262,066-2%-$423,341
DM
2018-02-09
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$78.32-86,36882,942-51%-$6,764,173
D
2018-02-05
NBIXObrien Christopher FlintFormer Chief Medical OfficerS - Sale+OE$83.18-2,61355,946-4%-$217,341
2018-02-05
NBIXLyons Gary ADirS - Sale$83.08-5,000267,066-2%-$415,380
D
2018-02-05
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$83.19-96015,318-6%-$79,863
D
2018-02-05
NBIXLippoldt DarinGCS - Sale+OE$83.12-2,73716,062-15%-$227,494
D
2018-02-05
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$83.09-2,04682,942-2%-$169,997
DM
2018-02-05
NBIXGorman Kevin CharlesCEOS - Sale+OE$80.25-105,983347,033-23%-$8,504,784
D
2018-02-05
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$83.10-2,262135,997-2%-$187,977
D
2018-02-05
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$83.14-8204,310-16%-$68,174
D
2018-02-05
NBIXGano KyleChief Business Development OffS - Sale+OE$83.05-2,04679,446-3%-$169,914
D
2018-01-24
NBIXRastetter William HDirS - Sale+OE$90.00-9,50024,750-28%-$855,000
2018-01-16
NBIXObrien Christopher FlintCHIEF MEDICAL OFFICERS - Sale$79.14-1,75050,723-3%-$138,499
2018-01-16
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$79.12-1,62579,316-2%-$128,563
2018-01-16
NBIXGorman Kevin CharlesCEOS - Sale$78.89-3,750336,357-1%-$295,820
2018-01-16
NBIXGano KyleChief Business Development OffS - Sale$79.05-1,62574,871-2%-$128,460
2018-01-16
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale$79.12-1,625131,226-1%-$128,575
D
2018-01-03
NBIXLippoldt DarinGCS - Sale+OE$79.36-1,97913,157-13%-$157,053
D
2018-01-02
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$77.52-18,08413,017-58%-$1,401,823
D
2017-12-28
NBIXLippoldt DarinGCS - Sale+OE$75.00-15,23713,157-54%-$1,142,775
D
2017-12-08
NBIXLippoldt DarinGCS - Sale+OE$75.00-2,95513,157-18%-$221,625
D
2017-12-04
NBIXLippoldt DarinGCS - Sale+OE$75.04-6,27913,157-32%-$471,160
2017-12-01
NBIXLyons Gary ADirS - Sale$72.92-10,000272,066-4%-$729,182
D
2017-11-15
NBIXLippoldt DarinGCS - Sale+OE$73.05-9,90013,157-43%-$723,191
2017-11-08
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$74.58-30,00077,691-28%-$2,237,343
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top